FDA Advisers Hold A Debate On Pfizer’s COVID Booster Injections
The Food and Drug Administration’s independent advisory panel plans to meet in a permanent session this Friday to review the most recently submitted Pfizer data. In this session, they will discuss whether a booster dose of this vaccine is safe Read More